reviewTop 10% cited
Anthrazykline in der Krebstherapie
Drugs · 1997 · Vol. 54(Supplement 4) · pp. 1–7
Gabriel N. Hortobágyi✉(The University of Texas MD Anderson Cancer Center)
Cancer Treatment and PharmacologyChemotherapy-induced cardiotoxicity and mitigationSynthesis and pharmacology of benzodiazepine derivativesMedicineTolerabilityAnthracyclineCardiotoxicityPharmacologyDaunorubicinDoxorubicinDexrazoxanePharmacokineticsToxicity
MeSH terms
Antibiotics, AntineoplasticDaunorubicinDoxorubicinHeart DiseasesHumansLeukemiaNeoplasmsNeutropeniaStomatitisDrug Resistance, Neoplasm
Citations
670
FWCI
3.90
field-weighted impact
References
49
Percentile
94%
vs. same field & year
Citations per year
Cited by
Drug-induced mitochondrial dysfunction and cardiotoxicity
American Journal of Physiology-Heart and Circulatory Physiology · 2015 · 513 citations
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Frontiers in Pharmacology · 2018 · 869 citations
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
Circulation · 2009 · 3,717 citations
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Journal of the American College of Cardiology · 2005 · 4,163 citations
References
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
Annals of Internal Medicine · 1979 · 2,419 citations
Polyethylenglykol-umhülltes (pegyliertes) liposomales Doxorubicin
Drugs · 1997 · 477 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.